# Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis

> **NCT05619302** · PHASE3 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 18 (actual)

## Conditions studied

- Cardiac Amyloidosis

## Interventions

- **DRUG:** [68Ga]CBP8 PET/MRI

## Key facts

- **NCT ID:** NCT05619302
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-03
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05619302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05619302, "Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05619302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*